Grant: Discovery Grants Program - Individual
McMaster University
$28,000.00
Application of machine learning in neuroscience
FY 2014-15
Summary
Major depressive disorder (MDD) is a serious mental condition that often completely debilitates a client. MDD is typically treated with one of several currently available antidepressant medications. However, the response rate to any of these medications is only about 30%. Unfortunately, there are currently no means for a priori assessment of whether a specific person will respond to a particular medication. Thus, in prescribing a treatment for MDD, the psychiatrist must by necessity resort to a trial-and-error procedure. This can result in long delays before remission and significant stress on the health care system. In conjunction with collaborating psychiatrists, the applicant has developed a preliminary EEG-based machine learning (ML) methodology that can predict the response of a person to an SSRI medication (which is one of the classes of anti-depressant treatment) before the therapy begins. It is clear that such a capability, when fully developed, will vastly improve the treatment of MDD. However, before this system can be exploited in clinical applications, significant further development of the ML methodology is required. The objective of the proposed research is therefore to develop new ML methods that can reliably predict response, not just to the SSRI class as is currently the case, but to a wider variety of pharmacological therapies. This requires development of new high-performance ML methods that are specific to this application. To improve performance, better classifiers and better features are required. We propose using EEG-based brain-source localization methods in conjunction with information theoretic criteria to identify brain sources that are directly associated with MDD. Extracting features from these sources should result in features with increased salience. We further intend to investigate improved classifier structures which can optimally exploit the nonstationarity and nonlinearity inherent in the underlying prediction model.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
6567-2011
Name nom
Reilly, James
Department département
Electrical and Computer Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2011
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
4
Nb partie
5
Application title
Application of machine learning in neuroscience
Keyword
NSERC
Application summary
Major depressive disorder (MDD) is a serious mental condition that often completely debilitates a client. MDD is typically treated with one of several currently available antidepressant medications. However, the response rate to any of these medications is only about 30%. Unfortunately, there are currently no means for a priori assessment of whether a specific person will respond to a particular medication. Thus, in prescribing a treatment for MDD, the psychiatrist must by necessity resort to a trial-and-error procedure. This can result in long delays before remission and significant stress on the health care system. In conjunction with collaborating psychiatrists, the applicant has developed a preliminary EEG-based machine learning (ML) methodology that can predict the response of a person to an SSRI medication (which is one of the classes of anti-depressant treatment) before the therapy begins. It is clear that such a capability, when fully developed, will vastly improve the treatment of MDD. However, before this system can be exploited in clinical applications, significant further development of the ML methodology is required. The objective of the proposed research is therefore to develop new ML methods that can reliably predict response, not just to the SSRI class as is currently the case, but to a wider variety of pharmacological therapies. This requires development of new high-performance ML methods that are specific to this application. To improve performance, better classifiers and better features are required. We propose using EEG-based brain-source localization methods in conjunction with information theoretic criteria to identify brain sources that are directly associated with MDD. Extracting features from these sources should result in features with increased salience. We further intend to investigate improved classifier structures which can optimally exploit the nonstationarity and nonlinearity inherent in the underlying prediction model.